Post-Doctoral Position available in Di Malta’s laboratory

TIGEM; Pozzuoli; À distance; EUR 25 000 - 30 000; Plein temps

Résumé du poste

TIGEM in Pozzuoli, Naples, Italy, invites applications for a Postdoctoral Fellow to join a dynamic research team focused on lysosomal dynamics and signaling. You’ll contribute to projects using biochemical, molecular, and cell biology approaches, imaging, genome editing, and multi-omics analyses, with mouse genetics integrated to assess physiological relevance.

The ideal candidate will have a PhD in biology or related field and proven experience in cellular and molecular biology; mouse genetics

Qualifications

• PhD in biology or related discipline.
• Experience in cellular and molecular biology.
• Mouse genetics experience appreciated.

Responsabilités

• Participate in projects studying lysosomal dynamics and signaling.
• Apply biochemical, molecular biology, imaging, genome editing, and mouse genetics to explore physiological relevance.

Connaissances

Cell biology techniques

Team collaboration

Independent thinking

Formation

PhD in biology or related discipline

Description du poste

Where:The workplace is the Telethon Institute of Genetics and Medicine located in Pozzuoli, Naples, Italy.
When:The position is available from January 2027.

What:We are seeking a highly motivated and talented Postdoctoral Fellow to join our research team. The successful candidate will participate in ongoing projects investigating the molecular mechanisms that control lysosomal dynamics and signaling, with the aim of elucidating their roles in physiology and disease. Our group combines biochemical, molecular, and cell biology approaches with advanced imaging, genome editing, and multi-omics analyses, and integrates mouse genetics to uncover the physiological relevance and pathological implications of lysosomal regulation. More information about the lab, the topics studied and latest publications are available at https://www.tigem.it/research/research-faculty/di-malta
Salary: €25,000-€30,000 gross per year, commensurate with research experience and scientific expertise.

Essentials:
The post-doctoral candidates should have a PhD in biology or a related discipline and preferably documented experience in cellular and molecular biology. Prior experience in mouse genetics is appreciated. The ideal candidate should be strongly motivated and able to work in a research team. Excellent technical skills and the ability to think independently and as part of a research team are highly desired. Records that show applicants ability to be funded will be positively considered.
TIGEM does not discriminate based on sex, race, gender orientation, sexuality, or disability. The selection committee for this role encourages applicants from all backgrounds and will consider all applications equally irrespective of the aforementionedcharacteristics.

TIGEM is a premier research center dedicated to understanding and treating genetic diseases. Established by Fondazione Telethon, the institute focuses on innovative research that bridges basic science and clinical applications. Renowned for its interdisciplinary approach, TIGEM unites experts in genomics, cell biology and gene therapy to uncover rare disease mechanisms and develop novel therapies. Housed in a refurbished 5,000-square-meter complex on the former Olivetti campus in Pozzuoli, the institute employs approximately 260 researchers from Italy and abroad across 24 independent research groups and seven state-of-the-art facilities, including advanced microscopy, bioinformatics, high-content screening, advanced histology and proteomics. The institute has made groundbreaking discoveries in lysosomal biology, membrane trafficking and autophagy regulation. Additionally, TIGEM is at the forefront of developing AAV-based gene therapy approaches, including clinical translation. The institute's commitment to advancing scientific knowledge is reflected in its active participation in international research networks and its role in training the next generation of scientists. Through partnerships with leading academic institutions and biotech companies, TIGEM continues to push the boundaries of genetic research, aiming to translate discoveries into effective treatments for patients worldwide.